UK-based Inquest into a hospice death raises more than a few questions.

There’s a fascinating Inquest (the name in the UK for a hearing charged with determining the cause of death in certain circumstances) taking place in London, which is due to resume in August.

It’s definitely worth reading the entire article. There are some astonishing and weird connections / coincidences set out:

Firstly:

The fact that the barrister representing the hospice had previously campaigned for Dr Luke Evans, who has been a Member of Parliament since 2019:

Who is this Dr Evans, you might ask?

Well, I actually mentioned him in my piece about euthanasia from last year, and by happenstance Substack selects the photo of the transcript of him speaking about midazolam as default when linking to it:

Did testing and euthanasia protocols help create the appearance of a sudden-spreading deadly novel virus?

·
June 2, 2024
Some people were onto the midazolam / euthanasia story from very early on.

Secondly:

Another eyebrow-raising connection relates to the doctor who was on duty during Mr Dimmock’s death:

The abstract of the paper written by Dr Wright can be found here.

Thirdly:

Then of course, there’s the fact that a day after the inquest began Sir Andrew Dillon resigned as a Director of the hospice where Mr Dimmock died.

Mr Dillon was the Chief Executive of NICE for over two decades until March 2020 when he stepped down.

NICE is a UK body responsible for writing clinical guidelines, and issued the notorious NG163 – end of life guidelines for covid patients – which appeared to simply mirror the advice appropriate for true end-of-life situations to “covid patients”, and about which concern was raised by UK-based palliative care specialists via a letter to the BMJ. NG163 is no longer available on NICE’s website and has been replaced by one (NG191) which no longer mentions midazolam.

It’s important to note that as far as I can find, Mr Dimmock died in June 2020, and Mr Dillon was not formally appointed as a Director of the hospice until 1 February 2021, though I have no idea whether he had any formal involvement in the hospice’s management before then.

This particular connection might be a coincidence. Becoming a trustee of a high-profile charity1 running a hospice in the city in which he works (and probably lives) would be a completely expected post-retirement activity, especially for someone who had had a career in public sector healthcare. Even if he had been on the Board of Trustees at the time, I consider it unlikely that Mr Dillon would have been involved in day-to-day hospice management to a degree and / or extent that he was linked to policy or events which contributed to Mr Dimmock’s death. Given that his appointment post-dated Mr Dimmock’s death anyway, any suggestion of a connection is surely tendentious.

Nonetheless, I do find the timing of his resignation curious, which does suggest that some “scrutiny avoidance” was going on because of the connection to NICE / NG163, hence it may have been deemed desirable to sever it.


The above could all be coincidences. Even if they are, the actual subject matter of this particular Inquest, which is scheduled to resume in August, should be of great interest but will, I have little doubt, receive virtually no mainstream media attention.

For specific testimony given at the Scottish Covid Inquiry relating to the use of midazolam and opiates to euthanise care home residents in Scotland (later all categorised as “covid deaths”), see the work of

, eg this article, which is just one of many:

1

The hospice is constituted as a limited company, so its charity trustees are also formally “Directors”, but this doesn’t indicate any more or less involvement in management of the entity than would be the case of an unincorporated charity with just “trustees” and no “directors”.

See more here Substack

Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.

Leave a comment

Save my name, email, and website in this browser for the next time I comment.
Share via